NIH in talks with Pfizer to study a longer course of COVID drug Paxlovid, Fauci says

Following reports of rebounding COVID-19 symptoms in people who took Pfizer's antiviral Paxlovid, the National Institutes of Health and the company are discussing testing a longer course of the antiviral, White House chief medical officer Dr. Anthony Fauci said on Wednesday.